trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
glycopyrronium bromide martindale pharmaceuticals 0,2 mg/ml raztopina za injiciranje
lenis d.o.o. - glikopironijev bromid - raztopina za injiciranje - glikopironijev bromid 0,2 mg / 1 ml - glikopironium
glycopyrronium bromide 0,2 mg/ml raztopina za injiciranje
sanolabor, d.d. - raztopina za injiciranje - glikopironium
glycopyrronium bromide 0,2 mg/ml raztopina za injiciranje
lenis d.o.o. - glikopironijev bromid - raztopina za injiciranje - glikopironijev bromid 0,2 mg / 1 ml - glikopironium
glycopyrronium bromide b. braun 0,2 mg/ml raztopina za injiciranje
glikopironijev bromid - raztopina za injiciranje - glikopironijev bromid 0,2 mg / 1 ml - glikopironium
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - pljučna bolezen, kronična obstruktivna bolezen - formoterol in glycopyrronium bromid - bevespi aerosphere je označen kot vzdrževanje bronchodilator zdravljenje za lajšanje simptomov pri odraslih bolnikih s kronično obstruktivno pljučno bolezen (kopb).
enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - zdravila za obstruktivne pljučne bolezni, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - zdravila za obstruktivne pljučne bolezni, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
enurev breezhaler
novartis europharm ltd - glycopyrronium bromid - pljučna bolezen, kronična obstruktivna bolezen - zdravila za obstruktivne pljučne bolezni, - zdravilo enurev breezhaler je indicirano za zdravljenje bronhodilatatorjev za vzdrževanje simptomov pri odraslih bolnikih s kronično obstruktivno pljučno boleznijo (kopb).